Skip to content

To evaluate the effect of herbal pain killer in the management of pain full periods

A double blind, standard control clinical study with a herbal pain killer (PP/JLN/106/2009-10) in the management of menstrual pain (Dysmenorrhoea)

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/02/012102
Enrollment
60
Registered
2018-02-23
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N944- Primary dysmenorrhea

Interventions

Intervention1: Tablet (JLN/PP/106C/09-10): Tablet contains Tagara, Ashoka & Bala. 1 to 2 tablets twice or thrice a day for 3 days and follow up for 2 weeks after the therapy Intervention2: Tablet (JLN

Sponsors

Dabur India Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Female in the reproductive age group 2. Females presenting with Dysmenorrhea with or without any of the following symptoms associated with mensturation: a. Any kind of pain: headache, abdominal pain, bodyache b. Nausea and Vomiting c. Weakness d. Psychological symptoms like anxiety, stress, depression, irritability, restlessness e. irregular cycles 3. Willingness to participate in the study and come for regular follow up as and when required 4. Readiness to sign Informed Consent Form

Exclusion criteria

Exclusion criteria: 1. Patients having organic causes of pain and menstrual abnormalities like uterine myeloma, adenomyosis, polyps, fibroids, endometriosis 2. Patients suffering from systemic or metabolic disorders like pituitary disease, diabetes mellitus, thyroid dysfunction and coagulation disorders 3. Patients having any other kind of chronic disease like respiratory or cardiac problems, HIV 4. Subjects not willing to sign Informed Consent Form 5. Patients participating in any other clinical study

Design outcomes

Primary

MeasureTime frame
Relief from dysmenorrhea and other related symptoms associated with menstruationTimepoint: Baseline(Day 0), Visit 1(Day 1), Visit 2(Day 3) & Visit 3(Day 17)

Secondary

MeasureTime frame
Overall safety of the subjects throughout the study periodTimepoint: Baseline(Day 0), Visit 1(Day 1), Visit 2(Day 3) & Visit 3(Day 17)

Countries

India

Contacts

Public ContactDr J L N Sastry

SJS Ayurvedic Hospital

lnsjata@yahoo.com8587076669

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026